Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

Novocure to Participate in Three Upcoming Investor Conferences

Business Wire August 6, 2019

Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update

Business Wire July 25, 2019

Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference

Business Wire July 22, 2019

CMS Establishes 2019 Monthly Fee Schedule Amount for Optune®

Business Wire July 18, 2019

Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

Business Wire July 18, 2019

Novocure to Report Second Quarter 2019 Financial Results

Business Wire July 2, 2019

German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optune's Survival Benefit for Patients with Newly Diagnosed Glioblastoma

Business Wire June 26, 2019

Novocure to Participate in the Jefferies 2019 Global Healthcare Conference

Business Wire May 24, 2019

FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma

Business Wire May 23, 2019

Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma

Business Wire May 10, 2019

Novocure Reports First Quarter 2019 Financial Results and Provides Company Update

Business Wire May 2, 2019

Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients

Business Wire April 30, 2019

Novocure Publishes 2018 Annual Report Featuring Company's Vision, Mission and Values

Business Wire April 15, 2019

Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019

Business Wire April 3, 2019

Novocure to Report First Quarter 2019 Financial Results

Business Wire April 2, 2019

Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer

Business Wire March 22, 2019

Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019

Business Wire March 21, 2019

Novocure’s Chief Science Officer Retires after 17 Years of Service

Business Wire March 21, 2019

Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference

Business Wire March 18, 2019

Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

Business Wire February 28, 2019